Skip to main navigation Skip to search Skip to main content

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience'. Together they form a unique fingerprint.
Sort by